维普中文期刊产品整合服务
21篇 您的检索式:作者名="Hallen G"
    题名 作者 年代 出处 被引量
1Improvement of Inner Quality of Continuously Cast Billets Using Electromagnetic Stirring and Thermal Soft Reduction显示文摘Sivesson P Hallen G Widell B 1998Ironmaking and Steelmaking1998,25,3:1
2Tolterodine-a new bladder selective muscarinic receptor antagonist: preclinical pharmacological and clinical data 显示文摘 Hallen B Larsson G 1997Life Sci1997,60,:1
3Tolterodine a new bladder selective muscarinic receptor antagonist:pre-clinical pharmacological and clinical data显示文摘Nilvebrant L Hallen B Larsson G 1997Life Sci1997,50,601:1
4Sulfur injection to remove copper from recycled lead 显示文摘PLASCENCIA G ROMERO A MORALES R HALLEN M CHAVEZ F 2001Canadian Metallurgical Quarterly2001,40,3:1
5Tolterodine in the treatment of overactive bladder: analysis of the pooled phase Ⅱ efficacy and safety data 显示文摘Larsson G Hallen B Nilvebrant L 1999Urology1999,53,5:1
6Hetetolocous trnsplantation with kid bone显示文摘 1996Acta Orthop Scand1996,37,:1
7Very low intensity alternating current decreases cell proliferation显示文摘Cucullo L Dini G Hallene KL 2005Glia2005,51,1:1
8Ion implan- tation processing and related effects in SiC 显示文摘SVENSSON B G HALLEN A WONG L J 2006Mater Sci Fo- rum2006,,:1
9Tolterodine - a new bladder selective muscarinic receptor antagonist:predinical pharmacological and clinical data显示文摘Nilvebrant L Hallen B Larsson G 1997Life Sci1997,60,1314:1
10Toherodine, a new bladder selective muscarinic receptor antagonist: Preclinical pharmacological and clinical data显示文摘Nilvebrant L Hallen B Larsson G 1997Life Sci1997,60,:1
11Toherodine in the treatment of overactive bladder: analysis of the pooled phase Ⅱ efficacy and safety data 显示文摘Larsson G Hallen B Nilvebrant L 1999Urology1999,53,:1
12Improvement of Inner Quality of Continuously Cast Billets Using Electromagnetic Stirring and Thermal Soft Reduction 显示文摘Sivesson P Hallen G Widell B 1998Ironmaking and Steelmaking1998,25,3:1
13Inhibition of the human sodium-bile acid cotransporters by side specific methanethiosul-fonate sulfhydryl reagents:substrate controlled accessi-bility of site of inactivation显示文摘Hallen S Fryklund J Sachs G 2000Biochemistry2000,39,:1
14Tolterodine-a new bladder selective muscarinic receptor antagonist: preclinical pharmacological and clinical data 显示文摘Nilvebrant L Hallen B Larsson G 1997Life Sci1997,60,1314:1
15Bacterial vaginosis-a boratory and clinical diagnostics enigma 显示文摘FORSUM U HALLEN A LARSSON P G 2005APMIS2005,113,3:1
16Tolterodine, a new bladder selective muscarinic receptor antagonist: Preclinical pharmacological and clinical data显示文摘Nilvebrant L Hallen B Larsson G 1997Life Sci1997,60,:1
17Tolterodine in the tretment of overative ldder : an analysis of the pooled phase Ⅱefficacy and safety data显示文摘 Hallen B Nilvebrandt L 1999Urology1999,53,5:1
18Improvement of Inner Qual-ity of Continuously Cast Billets Using Electromagnetic Stir-ring and Thermal Soft Reduction显示文摘Sivesson P Hallen G Widell B 1998Ironmaking and Steel-making1998,25,3:1
19Mechanical and microstructural characterization of Al-SiC composite material obtained by dynamic compaction显示文摘Jaramillo D Hinojosa G Hallen J M 1997Key Engineering Materials1997,,:1
20Toherodine-a new bladder selective muscarinic receptor antagonist: preclinical pharmacological and clinical data显示文摘NILVEBRANT L HALLEN B LARSSON G 1997Life Sci1997,60,1314:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费